AVE 16.7% 0.3¢ avecho biotechnology limited

media coverage, page-10

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    So the general consensus from both trials and those media priveleged who have been able to try this, is that it does what it purports to do. $99 for a monthly treatment. Do we think if someone is happy with the results that they will continue to use it? I do. So conservatively, once hooked, that's $1000 per year per client. What sort of marketshare could we consider? Let's say 10% of the Australia population is in the general target group, that's 2.2mill people. Could 1% of that target be achievable? Or 22,000? $1000 per year, that's $22mill. Profit per bottle. 40%? Split amongst two partners. 20% of $22mill = $4.4mill profit. PE of 20. There's close to POHs current marketcap just from sales in Australia. What happens when the rest of the world is targetted?

    Figures may be way off. Maybe they will never achieve these figures. Maybe we're being too enthusiastic (there you go dhukka). But at the very least it does highlight the huge potential.

    And this is just one of 18+ product pipelines POH are currently working on.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $2.099K 707.3K

Buyers (Bids)

No. Vol. Price($)
54 85992113 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 63266804 17
View Market Depth
Last trade - 15.59pm 30/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.